SOM 3.13% 31.0¢ somnomed limited

recession proof

  1. 16,474 Posts.
    lightbulb Created with Sketch. 776
    somnomed is a recession proof stock as stated by management.
    --------------

    SomnoMed Limited does not expect at this point in time that the Global Financial Crisis will impact significantly on its business, as the sleep disorder treatment markets are at a very early stage in their development and the need for treatment of obstructive sleep apnea is growing constantly disregarding of the economic circumstances.

    Demand for the SomnoDent MAS device is primarily driven by the growing number of patients diagnosed
    with obstructive sleep apnea, the significant number of patients who cannot tolerate or do not wish to use a
    CPAP mask and the growing support from sleep specialists around the world to use dental sleep devices as
    treatment for sleep apnea.
 
watchlist Created with Sketch. Add SOM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.